Dipexium Pharmaceuticals (DPRX) Soars as Japan Approves New Drug Patent: Locilex

The government of Japan has officially issued a patent for Locilex, a new topical skin infection treatment from Dipexium Pharmaceuticals (NASDAQ:DPRX). Shares of Dipexium shot up nearly 20 percent this afternoon after the patent approval was announced.